AB 315: Medi-Cal: Home and Community-Based Alternatives Waiver.
The bill aims to recast provisions for the home and community-based alternatives (HCBA) waiver, which provides care management services to individuals at risk of nursing facility or institutional placement. The bill requires the department to enroll all eligible individuals who apply for the waiver, rather than authorizing the expansion of waiver slots. By March 1, 2026, the department must seek necessary amendments to ensure sufficient capacity to enroll those on the waiting list. The bill also requires a rate study by March 1, 2026, to assess the sustainability, quality, and transparency of rates for the HCBA waiver.
| Feb. 02, 2026 | From committee: Filed with the Chief Clerk pursuant to Joint Rule 56. |
| Jan. 31, 2026 | Died pursuant to Art. IV, Sec. 10(c) of the Constitution. |
| May. 23, 2025 | In committee: Held under submission. |
| Apr. 09, 2025 | In committee: Set, first hearing. Referred to APPR. suspense file. |
| Mar. 26, 2025 | Coauthors revised. |
| Introduced by Assembly Member Bonta |
January 23, 2025 |
LEGISLATIVE COUNSEL'S DIGEST
The people of the State of California do enact as follows:
SECTION 1.
The Legislature finds and declares all of the following:SEC. 2.
Section 14132.991 of the Welfare and Institutions Code is amended to read:14132.991.
(a) When(3)Expand the number of waiver slots up to 5,000 additional slots, the director may seek federal approval to amend the waiver to add additional slots or make changes to the waiver model with approval from the Department of Finance.
(4)
(5)
(6)
(b)Notwithstanding Chapter 3.5 (commencing with Section 11340) of Part 1 of Division 3 of Title 2 of the Government Code, the department may implement, interpret, or make specific this section, in whole or in part, by means of all-county letters, plan letters, plan or provider bulletins, policy letters, or other similar instructions, without taking regulatory action.
(c)
(d)The department shall implement this section only to the extent it can demonstrate federal cost neutrality as required under the terms of the waiver, and only to the extent any necessary federal approvals are obtained and federal financial participation is available.